↓ Skip to main content

Clinical Trials of the BTK Inhibitors Ibrutinib and Acalabrutinib in Human Diseases Beyond B Cell Malignancies

Overview of attention for article published in Frontiers in oncology, October 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
38 Mendeley